Intrinsic Capacity Declines Faster After 75, Global Study Finds

Healthy aging is bigger than avoiding a diagnosis. It is the ability to think clearly, move safely, maintain energy, hear and see well enough to engage with the world, and sustain psychological well-being. The World Health Organization calls that combined reserve intrinsic capacity. A multinational analysis now finds that it declines with age, speeds up after 75, and follows different patterns across generations.

The result is useful as a population snapshot, not a personal protocol. Ying Li and colleagues' 2026 study pooled data from 172,751 community-dwelling adults aged 40 and older in 32 countries. It describes how a broad measure of function changed by age, sex, calendar period, and birth cohort. It cannot tell us whether a particular diet, supplement, exercise plan, health policy, or social condition caused those changes.

What intrinsic capacity measures

Intrinsic capacity combines five domains: cognition, locomotion, vitality, sensory function, and psychological capacity. The idea shifts attention away from disease counts alone. A person can have several well-managed diagnoses and remain highly functional; another can have few diagnoses documented yet struggle with mobility, memory, mood, nutrition, or hearing.

This framework has practical roots in the WHO Integrated Care for Older People, or ICOPE, approach. Community research using ICOPE has applied these domains to assess older adults, while researchers continue to test how well screening tools identify people at risk. For example, a 2023 VIMCI study evaluated diagnostic measures for identifying reduced intrinsic capacity in community-dwelling older people. A separate 2023 validation study examined the ICOPE tool's measurement structure and whether it predicted dependence and hospitalization.

That makes intrinsic capacity a sensible scoreboard for healthy aging. It is still a developing measurement system, however, not a universally standardized lab test with one immutable interpretation.

Capacity declines with age, especially after 75

Li et al. reported a gradual decline in intrinsic capacity as people aged, with faster decline after age 75. Women had a more pronounced late-life decline than men after 75. The publication's available summary does not report subgroup coefficients, confidence intervals, p-values, or absolute score changes for these contrasts. The appropriate conclusion is directional: late-life loss of combined physical and mental reserve accelerated, and the pattern was steeper in women.

The study also found that intrinsic capacity declined across the observation window, with the steepest decrease early in follow-up. Its birth-cohort findings did not point in one simple direction. Adults aged 80 and older in more recent birth cohorts had better intrinsic capacity, while younger people entering more recent cohorts had lower intrinsic capacity. Upward trends appeared only for certain age groups in high-income countries, rather than across the entire sample.

Those findings resist a tidy story about modern life making everyone healthier or sicker. Better capacity among later-born adults who reached age 80 could reflect improvements in living conditions or medical care. It could also partly reflect survivorship: people who live to advanced age may differ systematically from those who did not. Worse scores in younger recent cohorts deserve attention, but this descriptive analysis cannot identify their cause.

A broad score can predict outcomes without causing them

Other studies make intrinsic capacity clinically relevant. In a Mexican cohort of 7,263 adults aged 60 or older who did not have dementia at baseline, higher baseline intrinsic-capacity scores were associated with lower odds of incident dementia over three years: adjusted odds ratio 0.62, with a 95% confidence interval of 0.41 to 0.94. The result came from a 2026 study of older Mexicans; dementia incidence was 4.15% during follow-up.

A nationwide prospective Chinese cohort study of 10,751 adults aged 45 or older also reported that worsening intrinsic-capacity trajectories predicted higher incident stroke risk. That CHARLS analysis used Cox models with demographic, behavioral, and health-related adjustments. Prediction is not proof of causation. Low intrinsic capacity may capture early disease, accumulated disadvantage, or other risks that also raise the chance of stroke.

Related observational work points in the same practical direction without resolving that causal question. A prospective Spanish study measured physical activity and sedentary behavior with accelerometers and found that movement behaviors predicted subsequent changes in intrinsic capacity among community-dwelling adults aged 65 to 94. The Seniors-ENRICA-2 study supports physical activity as a plausible target, but its observational design cannot rule out reverse causation: people with better function may simply be more able to move.

Intervention evidence exists, but it is early

The field has moved beyond description. In an eight-week cluster randomized clinical trial, 240 women aged 60 or older were allocated equally to structured lifestyle counseling or no counseling during the study period. The intervention included eight small-group sessions lasting 30 to 45 minutes, addressing nutrition, exercise, psychological well-being, cognitive stimulation, and sensory health. The 2026 trial reported improved composite intrinsic capacity in the counseling group versus control.

That is stronger evidence for an intervention than an association study, but it does not establish a universal anti-aging program. The trial involved older women, lasted eight weeks, and measured composite capacity rather than long-term disability, dementia, stroke, or mortality. An umbrella review of nonpharmacological interventions found evidence across exercise, cognitive training, nutrition, and other approaches, while also reflecting substantial variation in methods and outcomes.

The measurement problem is real

Researchers generally agree on the five-domain concept. They do not yet use one identical instrument, set of tests, or cut points everywhere. Studies can assess the same domain with different questions or measures. That makes harmonized international comparisons valuable for seeing broad patterns, but it limits how literally readers should interpret a difference in composite score between countries or cohorts.

This limitation matters most for the 32-country analysis. The findings support comparison at the level of broad trends, not the claim that a one-point change carries precisely the same meaning in every setting. The ICOPE framework can also be implemented in real care settings, but evidence of feasibility is not evidence of large-scale effectiveness. A 2024 Singapore feasibility study showed that implementation can work in a specific context; health systems still need evidence that it scales reliably.

What this means for people chasing healthy aging

Intrinsic capacity is more useful than a single blood marker for judging whether an aging strategy improves life in the ways people actually notice. A claim about healthy aging should eventually show gains or slower decline across relevant functions, not merely a favorable movement in one surrogate measure.

Still, do not mistake this study for a prescription. The multinational trends do not identify the behavior or treatment that changed capacity, and the field has not settled on a single cross-country measurement standard. The next studies worth watching will standardize assessment across settings, test whether interventions improve intrinsic capacity and hard outcomes together, and show whether routine ICOPE-style assessment works outside pilot programs. Until then, intrinsic capacity is a promising scoreboard—one that needs clearer rules before anyone declares a winner.